ASCO Data Establish Chemo-IO as Mainstay Frontline for NSCLC

10:35 EDT 21 Jun 2018 | Medscape

Dr Jack West moderates a panel discussion with Drs Josh Bauml and Sandip Patel on the most important lung cancer trials at ASCO 2018, with a focus on chemo-immunotherapy combinations.
Medscape Oncology

Original Article: ASCO Data Establish Chemo-IO as Mainstay Frontline for NSCLC

More From BioPortfolio on "ASCO Data Establish Chemo-IO as Mainstay Frontline for NSCLC"